Objective: To determine the pharmacokinetics and pharmacodynamics of the neurosteroid anaesthetic, alfaxalone, in neonatal foals after a single intravenous (IV) injection of alfaxalone following premedication with butorphanol tartrate.
Study Design: Prospective experimental study.
Animals: Five clinically healthy Australian Stock Horse foals of mean ± SD age of 12 ± 3 days and weighing 67.3 ± 12.4 kg.
Methods: Foals were premedicated with butorphanol (0.05 mg kg(-1) IV) and anaesthesia was induced 10 minutes later by IV injection with alfaxalone 3 mg kg(-1) . Cardiorespiratory variables (pulse rate, respiratory rate, direct arterial blood pressure, arterial blood gases) and clinical signs of anaesthetic depth were evaluated throughout anaesthesia. Venous blood samples were collected at strategic time points and alfaxalone plasma concentrations were assayed using liquid chromatography-mass spectrometry (LC/MS) and analysed by noncompartmental pharmacokinetic analysis.
Results: The harmonic, mean ± SD plasma elimination half life (t½) for alfaxalone was 22.8 ± 5.2 minutes. The observed mean plasma clearance (Cl(p) ) and volume of distribution (Vd) were 19.9 ± 5.9 mL minute kg(-1) and 0.6 ± 0.2 L kg(-1) , respectively. Overall, the quality of the anaesthetic inductions and recoveries was good and most monitored physiological variables were clinically acceptable in all foals, although some foals became hypoxaemic for a short period following recumbency. The mean durations of anaesthesia from induction to first movement and from induction to standing were 18.7 ± 7 and 37.2 ± 4.7 minutes, respectively.
Conclusions: The anaesthetic protocol used provided a predictable and consistent plane of anaesthesia in the five foals studied, with minimal cardiovascular depression. In foals, as in the adult horse, alfaxalone has a short elimination half life.
Clinical Relevance: Alfaxalone appears to be an adequate anaesthetic induction agent in foals and the pharmacokinetics suggest that, with continuous infusion, it might be suitable to provide more prolonged anaesthesia. Oxygen supplementation is recommended.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1467-2995.2012.00734.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy.
Int J Biol Macromol
December 2024
Department of Biotechnology, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi 110025, India. Electronic address:
PIM-1 kinase, a member of the Serine/Threonine kinase family, has emerged as a promising therapeutic target in various cancers due to its role in promoting tumor growth and resistance to conventional therapies. In this study, we employed a structure-based approach to screen 3800 FDA-approved drugs to discover potential inhibitors of PIM-1. After an initial selection of 50 candidates based on high docking scores, four drugs, stanozolol, alfaxalone, rifaximin, and telmisartan, were identified as strong PIM-1 binders, interacting with key residues in the ATP-binding pocket of the kinase.
View Article and Find Full Text PDFEfficacy of transdermal ketoprofen on surgical inflammation in dogs.
Res Vet Sci
December 2024
School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia. Electronic address:
Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation in dogs. Despite having effective analgesic efficacy, prolonged oral administration has been associated with adverse effects. Transdermal delivery of ketoprofen has reduced the incidence of adverse effects in humans and could potentially be used in veterinary clinical medicine.
View Article and Find Full Text PDFBlind supratemporal retrobulbar block in cats: a feasibility cadaveric study and its efficacy in a group of subjects undergoing corneal or intraocular surgery.
Front Vet Sci
November 2024
Department of Veterinary Science, University of Turin, Turin, Italy.
Article Synopsis
- The study investigates the supratemporal retrobulbar block as an anesthetic technique in cats, addressing its effectiveness and injection methods.
- A modified injection of a specific mixture was performed on cadavers, showing a high success rate in contrast agent spread and good distribution around the optic nerve.
- In a clinical setting with 12 cats, the retrobulbar group experienced fewer anesthetist interventions compared to the control group, indicating a potential advantage of the supratemporal approach for surgeries.
Sedative effects of intramuscular alfaxalone-methadone-midazolam versus ketamine-methadone-midazolam in cats.
Vet Anaesth Analg
January 2025
Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands; Department of Clinical Sciences and Services, Royal Veterinary College, Hertfordshire, UK.
Objective: To assess depth and quality of sedation and the ability to place an intravenous catheter in cats after intramuscular (IM) injection with alfaxalone-methadone-midazolam (AMM) or ketamine-methadone-midazolam (KMM).
Study Design: Blinded randomized clinical trial.
Animals: A group of 46 healthy Domestic Short Hair cats.
Effects of hydromorphone alone and combined with medetomidine-vatinoxan or dexmedetomidine on alfaxalone induction dose and mean arterial pressure in dogs anesthetized with sevoflurane.
Vet Anaesth Analg
January 2025
Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.
Article Synopsis
- - The study aimed to determine how different sedation protocols (MVH, DH, H) affected the amount of alfaxalone needed for anesthesia in healthy Beagle dogs and to assess various cardiopulmonary metrics.
- - In this experiment, dogs premedicated with MVH required less alfaxalone for induction compared to those given DH or H and experienced a higher incidence and duration of hypotension during anesthesia.
- - The findings suggest that while MVH is effective for reducing alfaxalone dosage, it may lead to significant drops in arterial pressure, indicating a trade-off in its clinical use.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!